Table of Content

1. Report Scope and Methodology

1.1 Scope of the Report

1.2 Research Methodology

1.3 Executive Summary


2. Strategic Recommendations


3. Global Active Pharmaceutical Ingredient Market: Product Outlook


4. Global Active Pharmaceutical Ingredient Market: Size and Forecast

4.1 Global Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026


5. Global Active Pharmaceutical Ingredient Market Segmentation – By Application, By Drug Type, By Synthesis

5.1 Competitive Scenario of Global Active Pharmaceutical Ingredient Market: By Application

5.1.1 Oncology – Market Size and Forecast (2016-2026)

5.1.2 Cardiology– Market Size and Forecast (2016-2026)

5.1.3 Diabetes – Market Size and Forecast (2016-2026)

5.1.4 Neurology – Market Size and Forecast (2016-2026)

5.1.5 Others – Market Size and Forecast (2016-2026)

5.2 Competitive Scenario of Global Active Pharmaceutical Ingredient Market: By Drug Type

5.2.1? Generic API– Market Size and Forecast (2016-2026)

5.2.2 Innovative API – Market Size and Forecast (2016-2026)

5.3 Competitive Scenario of Global Active Pharmaceutical Ingredient Market: By Synthesis

5.3.1 Synthetic – Market Size and Forecast (2016-2026)

5.3.2 Biotech – Market Size and Forecast (2016-2026)


6. Global Active Pharmaceutical Ingredient Market: Regional Analysis

6.1 Competitive Scenario of Global Active Pharmaceutical Ingredient Market: By Region


7. North America Active Pharmaceutical Ingredient Market: An Analysis (2016-2026)

7.1 North America Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026)

7.2 North America Active Pharmaceutical Ingredient Market – Prominent Companies

7.3 Market Segmentation By Application (Oncology, Cardiology, Diabetes, Neurology and Others)?

7.4 Market Segmentation By Drug Type (Generic API and Innovative API)?

7.5 Market Segmentation By Synthesis (Synthetic and Biotech)?

7.6 North America Active Pharmaceutical Ingredient Market: Country Analysis?

7.7 Market Opportunity Chart of North America Active Pharmaceutical Ingredient Market - By Country, By Value, 2026

7.8 Competitive Scenario of North America Active Pharmaceutical Ingredient Market: By Country

7.9 United States Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

7.10 United States Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)

7.11 Canada Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

7.12 Canada Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)


8. Europe Active Pharmaceutical Ingredient Market: An Analysis (2016-2026)

8.1 Europe Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

8.2 Europe Active Pharmaceutical Ingredient Market – Prominent Companies

8.3 Market Segmentation By Application (Oncology, Cardiology, Diabetes, Neurology and Others)?

8.4 Market Segmentation By Drug Type (Generic API and Innovative API)?

8.5 Market Segmentation By Synthesis (Synthetic and Biotech)?

8.6 Europe Active Pharmaceutical Ingredient Market: Country Analysis?

8.7 Market Opportunity Chart of Europe Active Pharmaceutical Ingredient Market - By Country, By Value, 2026

8.8 Competitive Scenario of Europe Active Pharmaceutical Ingredient Market: By Country

8.9 Germany Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

8.10 Germany Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)

8.11 United Kingdom Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

8.12 United Kingdom Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)

8.13 France Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

8.14 France Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)

8.15 Spain Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

8.16 Spain Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)

8.17 Italy Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

8.18 Italy Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)


9. Asia Pacific Active Pharmaceutical Ingredient Market: An Analysis (2016-2026)

9.1 Asia Pacific Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

9.2 Asia Pacific Active Pharmaceutical Ingredient Market – Prominent Companies

9.3 Market Segmentation By Application (Oncology, Cardiology, Diabetes, Neurology and Others)?

9.4 Market Segmentation By Drug Type (Generic API and Innovative API)?

9.5 Market Segmentation By Synthesis (Synthetic and Biotech)?

9.6 Asia Pacific Active Pharmaceutical Ingredient Market: Country Analysis?

9.7 Market Opportunity Chart of Asia Pacific Active Pharmaceutical Ingredient Market - By Country, By Value, 2026

9.8 Competitive Scenario of Asia Pacific Active Pharmaceutical Ingredient Market: By Country

9.9 China Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

9.10 China Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)

9.11 Japan Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

9.12 Japan Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)

9.13 India Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value

9.14 India Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)


10. Global Active Pharmaceutical Ingredient Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Trends


11. Market Attractiveness

11.1 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market – By Application, 2026

11.2 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market - By Drug Type, 2026

11.3 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market - By Synthesis, 2026

11.4 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market - By Region, 2026

12. Competitive Landscape

12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers

12.2 Market Share Analysis

13. Company Analysis

13.1 Pfizer Inc.,

13.2 GlaxoSmithKline

13.3 AbbVie Inc.

13.4 Novartis AG

13.5 Eli Lilly and Company

13.6 Merck KGaA

13.7 Teva Pharmaceutical Industries Ltd.

13.8 Sanofi

13.9 Bristol-Myers Squibb

13.10 Boehringer Ingelheim



List of Figures

List of Figures

Figure 1: Global Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 2: Percentage of API manufacturing facilities for all drugs (August 2019)

Figure 3: World’s leading causes of death (in millions), 2019

Figure 4: World Population 65 Years & Above (% of Total), 2015-2019

Figure 5: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)

Figure 6: Estimated number of new cases in 2020, worldwide, both sexes, all ages

Figure 7: Global Active Pharmaceutical Ingredient Market-By Application Market Share, 2020 & 2026

Figure 8: Global Active Pharmaceutical Ingredient Market- By Oncology, By Value (USD Billion), 2016-2026

Figure 9: Global Active Pharmaceutical Ingredient Market- By Cardiology, By Value (USD Billion), 2016-2026

Figure 10: Global Active Pharmaceutical Ingredient Market- By Diabetes, By Value (USD Billion), 2016-2026

Figure 11: Global Active Pharmaceutical Ingredient Market- By Neurology, By Value (USD Billion), 2016-2026

Figure 12: Global Active Pharmaceutical Ingredient Market- By Others, By Value (USD Billion), 2016-2026

Figure 13: Global Active Pharmaceutical Ingredient Market- By Drug Type Market Share, 2020 & 2026

Figure 14: Global Active Pharmaceutical Ingredient Market- By Generic API, By Value (USD Billion), 2016-2026

Figure 15: Global Active Pharmaceutical Ingredient Market- By Innovative API, By Value (USD Billion), 2016-2026

Figure 16: Global Active Pharmaceutical Ingredient Market- By Synthesis Market Share, 2020 & 2026

Figure 17: Global Active Pharmaceutical Ingredient Market- By Synthetic, By Value (USD Billion), 2016-2026

Figure 18: Global Active Pharmaceutical Ingredient Market- By Biotech, By Value (USD Billion), 2016-2026

Figure 19: Global Active Pharmaceutical Ingredient Market- By Region Market Share, 2020 & 2026

Figure 20: North America Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 21: North America Prevalence of Neurological Disorders, 2015-2019 (In Millions)

Figure 22: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)

Figure 23: North America Urban population, 2015-2018 (In %)

Figure 24: North America Active Pharmaceutical Ingredient players market share (%), 2020

Figure 25: North America Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 26: North America Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 27: North America Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 28: Market Opportunity Chart of North America Active Pharmaceutical Ingredient Market- By Country, By Value (Year 2016-2026)

Figure 29: North America Active Pharmaceutical Ingredient Market- By Country Market Share, 2020 & 2026

Figure 30: United States Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 31: United State year-on-year growth of Active Pharmaceutical Ingredient (in %), (2017-2026)

Figure 32: United State population aged 65 and above, (in % of total population), 2016-2020

Figure 33: United State health expenditure (% of GDP), 2013-2018

Figure 34: United State Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 35: United State Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 36: United State Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 37: Canada Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 38: Canada population aged 65 and above (% of total population), 2016-2020

Figure 39: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)

Figure 40: Canada Urban population, 2015-2019 (In %)

Figure 41: Canada Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 42: Canada Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 43: Canada Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 44: Europe Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 45: Europe current health expenditure (% of GDP), (2014-2018)

Figure 46: Europe population aged 65 and above (% of total population), 2020

Figure 47: Europe percentage of dying between age 30 to 70 from any cardiovascular disease, cancer, diabetes and chronic respiratory disease, 2019

Figure 48: Europe Active Pharmaceutical Ingredient players market share (%), 2020

Figure 49: Europe Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 50: Europe Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 51: Europe Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 52: Market Opportunity Chart of Europe Active Pharmaceutical Ingredient Market- By Country, By Value (Year 2016-2026)

Figure 53: Europe Active Pharmaceutical Ingredient Market- By Country Market Share, 2020 & 2026

Figure 54: Germany Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 55: Germany current health expenditure (% of GDP), (2014-2018)

Figure 56: Germany population aged 65 and above (% of total population), 2016-2020

Figure 57: Germany urban population (% of total population), 2016-2019

Figure 58: Germany Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 59: Germany Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 60: Germany Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 61: United Kingdom Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 62: United Kingdom current health expenditure (% of GDP), (2014-2018)

Figure 63: United Kingdom population aged 65 and above (% of total population), 2016-2020

Figure 64: United Kingdom urban population (in millions), 2016-2020

Figure 65: United Kingdom Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 66: United Kingdom Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 67: United Kingdom Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 68: France Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 69: France current health expenditure (% of GDP), (2014-2018)

Figure 70: France urban population (% of total population), 2016-2020

Figure 71: France population aged 65 and above (% of total population), 2016-2020

Figure 72: France Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 73: France Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 74: France Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 75: Spain Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 76: Spain current health expenditure (% of GDP), (2014-2018)

Figure 77: Spain population aged 65 and above (% of total population), 2016-2020

Figure 78: Spain urban population (% of total population), 2016-2020

Figure 79: Spain Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 80: Spain Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 81: Spain Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 82: Italy Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 83: Italy current health expenditure (% of GDP), (2014-2018)

Figure 84: Italy population aged 65 and above (% of total population), 2016-2020

Figure 85: Italy urban population (% of total population), 2016-2020

Figure 86: Italy Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 87: Italy Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 88: Italy Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 89: Asia Pacific Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 90: Asia Pacific urban population (% of total population), 2016-2020

Figure 91: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)

Figure 92: Asia Pacific population aged 65 years and above (% of total population), 2016-2020

Figure 93: Asia Pacific Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 94: Asia Pacific Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 95: Asia Pacific Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 96: Market Opportunity Chart of APAC Active Pharmaceutical Ingredient Market- By Country, By Value (Year-2026)

Figure 97: APAC Active Pharmaceutical Ingredient Market- By Country Market Share, 2020 & 2026

Figure 98: China Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 99: China total population in billions, 2016-2020

Figure 100: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)

Figure 101: China export destinations of Active Pharmaceutical Ingredient, 2019

Figure 102: China Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 103: China Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 104: China Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 105: Japan Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 106: Japan population above 65 years (% of total population), 2016-2020

Figure 107: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)

Figure 108: Japan urban population (in millions), 2016-2020

Figure 109: Japan Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 110: Japan Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 111: Japan Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026

Figure 112: India Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)

Figure 113: India Current Healthcare Expenditure (% of GDP), 2015-2018

Figure 114: India population (in billions), 2016-2020

Figure 115: India urban population (% of total population), 2015-2019

Figure 116: India Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026

Figure 117: India Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026

Figure 118: India Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Million), 2016-2026

Figure 119: Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Application (Year-2016-2026)

Figure 120: Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Drug Type (Year 2016-2026)

Figure 121: Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Synthesis (Year 2016-2026)

Figure 122: Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Region (Year 2016-2026)

Figure 123: Global Active Pharmaceutical Ingredient players market share (%), 2020

Figure 124: Pfizer Inc., Annual Sales Revenue (USD Million), 2016-2020

Figure 125: Pfizer Inc., Annual Net Income/Loss (USD Million), 2016-2020

Figure 126: Pfizer Inc., sales Revenue, By Geographical Segment (%), FY2020

Figure 127: GlaxoSmithKline Annual Sales Revenue (USD Million), 2016-2020

Figure 128: GlaxoSmithKline Gross Profit (USD Million), 2016-2020

Figure 129: GlaxoSmithKline Sales Revenue Split, By Business Segment (%), FY2020

Figure 130: GlaxoSmithKline Sales Revenue Split, By Geography Segment (%), FY2020

Figure 131: AbbVie Inc. Annual Sales Revenue (USD Million), 2016-2020

Figure 132: AbbVie Inc. Net Income (USD Million), 2016-2020

Figure 133: AbbVie Inc. Sales Revenue Split, By Business Segment (%), FY2020

Figure 134: AbbVie Inc. Sales Revenue Split, By Geography Segment (%), FY2020

Figure 135: Novartis Annual Sales Revenue (USD Million), 2016-2020

Figure 136: Novartis Annual Net Income/Loss (USD Million), 2016-2020

Figure 137: Novartis Sales Revenue Split, By Business Segment (USD Million), FY2020

Figure 138: Novartis Sales Revenue Split, By Geography Segment (%), FY2020

Figure 139: Eli Lilly and Company Annual Sales Revenue (USD Million), 2016-2020

Figure 140: Eli Lilly and Company Annual Net Income (USD Million), 2016-2020

Figure 141: Eli Lilly and Company Sales Revenue Split, By Business Segment (USD Million), FY2020

Figure 142: Eli Lilly and Company Sales Revenue Split, By Geography Segment (%), FY2020

Figure 143: Merck KGaA Sales Revenues, 2016-2020 (USD Million)

Figure 144: Merck KGaA Gross Profit, 2016-2020 (USD Million)

Figure 145: Merck KGaA Sales Revenue Split, By Business Segment (%), FY2020

Figure 146: Merck KGaA Sales Revenue Split, By Geography Segment (%), FY2020

Figure 147: Teva Pharmaceutical Industries Ltd. Sales Revenues, 2016-2020 (USD Million)

Figure 148: Teva Pharmaceutical Industries Ltd. Net Income, 2016-2020 (USD Million)

Figure 149: Teva Pharmaceutical Industries Ltd. sales Revenues, By Business Segment (%) in North America, FY2020

Figure 150: Teva Pharmaceutical Industries Ltd. sales Revenue, By Geographical Segment (%), FY2020

Figure 151: Sanofi Sales Revenues, 2016-2020 (USD Million)

Figure 152: Sanofi Gross Profit, 2016-2020 (USD Million)

Figure 153: Sanofi Sales Revenue Split, By Business Segment (%), FY2020

Figure 154: Sanofi Sales Revenue Split, By Geography Segment (%), FY2020

Figure 155: Bristol-Myers Squibb Sales Revenues, 2016-2020 (USD Million)

Figure 156: Bristol-Myers Squibb Net Income, 2016-2020 (USD Million)

Figure 157:?Bristol-Myers Squibb Sales Revenue Split, By Business Segment (%), FY2020

Figure 158: Bristol-Myers Squibb Sales Revenue Split, By Geography Segment (%), FY2020

Figure 159: Boehringer Ingelheim Revenues, 2016-2020 (USD Million)

Figure 160:?Boehringer Ingelheim Net Income/Loss, 2016-2020 (USD Million)

Figure 161: Boehringer Ingelheim Sales Revenue Split, By Business Segment (%), FY2020

Figure 162: Boehringer Ingelheim Sales Revenue Split, By Geography Segment (%), FY2020